Description:
PIEBALD TRAIT; PBT
V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; KIT
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Other Disorders of Known Biochemistry |
Alternate IDs |
GM17369 [PIEBALD TRAIT; PBT] |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Race
|
White
|
Ethnicity
|
ASHKENAZI
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a positive result with a primer for Yq11, DYS227. |
|
Gene |
KIT |
Chromosomal Location |
4q12 |
Allelic Variant 1 |
164920.0001; PIEBALDISM |
Identified Mutation |
GLY664ARG; Reasoning that human piebaldism (172800), like mouse dominant white spotting (W), might be a result of mutation in the KIT gene, Spritz and Giebel [Am. J. Hum. Genet. 49 (Supplement): 38 (1991)] and Giebel and
Spritz [Proc. Natl. Acad. Sci., USA 88: 8696-8699 (1991)] designed primers for PCR amplification of the 21 coding exons. Studies of DNA from a patient with classic autosomal dominant piebaldism showed that he was heterozygous for a single base change, resulting in a glycine-to-arginine substitution at codon 664, within the ATP-binding site of the tyrosine kinase domain. |
Remarks |
Ashkenazi; 6 aff generations; patches of absent pigmentation on chest, abdomen, & limbs; no anemia; others in kindred have white forelock &/or constipation; heterozygous for a GGG(gly)>AGG(Arg) substitution at codon 664 [Gly664Arg (G664R)] of c-kit proto-oncogene (KIT) |
|
|